Cargando…
PBPK Model of Morphine Incorporating Developmental Changes in Hepatic OCT1 and UGT2B7 Proteins to Explain the Variability in Clearances in Neonates and Small Infants
Morphine has large pharmacokinetic variability, which is further complicated by developmental changes in neonates and small infants. The impacts of organic cation transporter 1 (OCT1) genotype and changes in blood‐flow on morphine clearance (CL) were previously demonstrated in children, whereas chan...
Autores principales: | Emoto, Chie, Johnson, Trevor N., Neuhoff, Sibylle, Hahn, David, Vinks, Alexander A., Fukuda, Tsuyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063742/ https://www.ncbi.nlm.nih.gov/pubmed/29920988 http://dx.doi.org/10.1002/psp4.12306 |
Ejemplares similares
-
Characterization of Contributing Factors to Variability in Morphine Clearance Through PBPK Modeling Implemented With OCT1 Transporter
por: Emoto, C, et al.
Publicado: (2016) -
Using a Vancomycin PBPK Model in Special Populations to Elucidate Case‐Based Clinical PK Observations
por: Emoto, Chie, et al.
Publicado: (2018) -
A Theoretical Physiologically‐Based Pharmacokinetic Approach to Ascertain Covariates Explaining the Large Interpatient Variability in Tacrolimus Disposition
por: Emoto, Chie, et al.
Publicado: (2019) -
Characterizing the Developmental Trajectory of Sirolimus Clearance in Neonates and Infants
por: Emoto, C, et al.
Publicado: (2016) -
More Power to OATP1B1: An Evaluation of Sample Size in Pharmacogenetic Studies Using a Rosuvastatin PBPK Model for Intestinal, Hepatic, and Renal Transporter‐Mediated Clearances
por: Emami Riedmaier, Ariane, et al.
Publicado: (2016)